Thank you, Mr. Chair, and thank you to the witnesses for being here.
I would like to just ask a few questions, focusing on the health side of this. I was interested to hear Mr. Perry's comments--they had kind of a narrow focus--on being concerned about B.C.
I'm from eastern Canada. It was very acute out there. We had hundreds of procedures cancelled in Nova Scotia. We had our Moncton hospital, which is very well known for cancer care and heart care, cancelling procedures. River Valley Health services, a predominant portion of which is in my riding of Tobique--Mactaquac, does 70 diagnostics a week, and these were all going to be put off. So I suggest that there's been quite an impact from that standpoint.
Dr. Gulenchyn, I wanted to ask you a question. You are part of this ad hoc working group and an advisory panel. Who were the major players? When I say “who”, I mean what types of people were part of that advisory panel? Seeing as you are the medical chief in the department of nuclear medicine—